Cilastatin is used to treat certain serious infections that are caused by bacteria, including endocarditis and respiratory tract, urinary tract, abdominal, gynecological, blood, skin, bone, and joint infections. Reference standards of Cilastatin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Cilastatin Ammonium Salt
Catalogue No.:PA 30 20510
CAS :
Molecular Formula : C16H29N3O5S
Molecular Weight : 375.48
Cilastatin Ammonium Salt (1134051)
Catalogue No.:PA USP1134051
Molecular Formula : NA
Molecular Weight : NA
Cilastatin for system suitability 1 (Y0001651)
Catalogue No.:PA EPY0001651
Cilastatin sodium (C2170000)
Catalogue No.:PA EPC2170000
Cilastatin for system suitability 2 (Y0001652)
Catalogue No.:PA EPY0001652
Catalogue No.:PA IPIPRS 83 12
Molecular Formula :
Catalogue No.:PAI 03 025010
Molecular Formula : C16H26N2O5S
Molecular Weight : 358.45
Cilastatin
Catalogue No.:PA 82 23000
(S,Z)-7-Chloro-2-(2,2-dimethylcyclopropane-1-carboxamido)hept-2-enoic acid
Catalogue No.:PA 82 0231000
Molecular Formula : C13H20ClNO3
Molecular Weight : 273.76
(Z)-7-(((S)-2-Amino-2-Carboxyethyl)thio)-2-((S)-2,2-Dimethylcyclopropane-1-Carboxamido)hept-2-enoic Acid
Catalogue No.:PA 82 0231001
7-Chloro-2-(2,3-dimethylbut-3-enamido)hept-2-enoic Acid
Catalogue No.:PA 82 0231004
7-((2-Amino-2-carboxyethyl)thio)-2-(2,2-dimethylcyclopropane-1-carboxamido)hept-2-enoic Acid
Catalogue No.:PA 82 0231003
Ethyl (S,E)-7-chloro-2-(2,2-dimethylcyclopropane-1-carboxamido)hept-2-enoate
Catalogue No.:PA 82 0231005
Molecular Formula : C15H24ClNO3
Molecular Weight : 301.81
Ethyl (Z)-2-amino-7-chlorohept-2-enoate
Catalogue No.:PA 82 0231006
Molecular Formula : C9H16ClNO2
Molecular Weight : 205.68
(Z)-7-(((S)-2-Carboxy-2-((S)-2,2-dimethylcyclopropane-1-carboxamido)ethyl)thio)-2-((S)-2,2-dimethylcyclopropane-1-carboxamido)hept-2-enoic Acid
Catalogue No.:PA 82 0231007
Molecular Formula : C22H34N2O6S
Molecular Weight : 454.58
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
